Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Total 13F shares
-
81,489,147
-
Share change
-
-5,875,634
-
Total reported value
-
$1,813,024,077
-
Put/Call ratio
-
71%
-
Price per share
-
$22.25
-
Number of holders
-
224
-
Value change
-
-$128,901,748
-
Number of buys
-
89
-
Number of sells
-
128
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2023
As of 30 Jun 2023 CORCEPT THERAPEUTICS INC - Common Stock (CORT) had 224 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 81,489,147 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, Parallel Advisors, LLC, Novo Holdings A/S, STATE STREET CORP, FEDERATED HERMES, INC., DIMENSIONAL FUND ADVISORS LP, and Boston Trust Walden Corp.
This table shows 224 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.